These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3297733)

  • 1. The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: comparison with patients with normal renal function.
    Drummer OH; Workman BS; Miach PJ; Jarrott B; Louis WJ
    Eur J Clin Pharmacol; 1987; 32(3):267-71. PubMed ID: 3297733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of captopril in patients undergoing continuous ambulatory peritoneal dialysis.
    Fujimura A; Kajiyama H; Ebihara A; Iwashita K; Nomura Y; Kawahara Y
    Nephron; 1986; 44(4):324-8. PubMed ID: 3025754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of oral nitrendipine solution in hypertensive patients with advanced renal failure.
    Kierdorf H; Müller A; Blanke PM; Gellert J; Heintz B; Rämsch KD; Wargenau M; Kindler J
    Eur J Clin Pharmacol; 1993; 45(2):129-34. PubMed ID: 8223833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination kinetics of captopril in patients with renal failure.
    Duchin KL; Pierides AM; Heald A; Singhvi SM; Rommel AJ
    Kidney Int; 1984 Jun; 25(6):942-7. PubMed ID: 6381858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.
    Giudicelli JF; Chaignon M; Richer C; Giroux B; Guedon J
    Br J Clin Pharmacol; 1984 Nov; 18(5):749-58. PubMed ID: 6095887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cilazapril in patients with renal failure.
    Fillastre JP; Moulin B; Godin M; Williams PE; Brown AN; Francis RJ; Pinta P; Manfredi R
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):275S-282S. PubMed ID: 2527539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.
    Duchin KL; McKinstry DN; Cohen AI; Migdalof BH
    Clin Pharmacokinet; 1988 Apr; 14(4):241-59. PubMed ID: 3292102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of captopril plus its disulfide metabolites in human plasma].
    Zhong D; Li X; Wang A; Chen X
    Yao Xue Xue Bao; 1998 Aug; 33(8):605-9. PubMed ID: 12016901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uneventful self poisoning with a very high dose of captopril.
    Lechleitner P; Dzien A; Haring C; Glossmann H
    Toxicology; 1990 Dec; 64(3):325-9. PubMed ID: 2148447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postexercise hypotension induced by low-intensity resistance exercise in hypertensive women receiving captopril.
    Melo CM; Alencar Filho AC; Tinucci T; Mion D; Forjaz CL
    Blood Press Monit; 2006 Aug; 11(4):183-9. PubMed ID: 16810028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
    Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease.
    Sinaiko AR; Mirkin BL; Hendrick DA; Green TP; O'Dea RF
    J Pediatr; 1983 Nov; 103(5):799-805. PubMed ID: 6355421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.
    Ohman KP; Kågedal B; Larsson R; Karlberg BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S20-4. PubMed ID: 2580171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of captopril, reducible captopril conjugates and S-methylcaptopril in the rat.
    Drummer OH; Worland PJ; Jarrott B
    Biochem Pharmacol; 1983 May; 32(10):1563-8. PubMed ID: 6344870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and biological effects of captopril and hydrochlorothiazide after acute and chronic administration either alone or in combination in hypertensive patients.
    Giudicelli JF; Richer C; Mattei A
    Br J Clin Pharmacol; 1987; 23 Suppl 1(Suppl 1):51S-63S. PubMed ID: 3034318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
    Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with captopril in pediatric patients with severe hypertension and chronic renal failure.
    Callis L; Vila A; Catalá J; Gras X
    Clin Exp Hypertens A; 1986; 8(4-5):847-51. PubMed ID: 3530558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of captopril on severe renin-dependent hypertension of uraemics on regular dialysis treatment.
    Pyrpasopoulos M; Sion M; Paraskevopoulos G; Zuruzoglu W; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(2):131-4. PubMed ID: 6348445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.